Lantheus Holdings, Inc. (LNTH)
As of Sep 19, 2026, Lantheus Holdings, Inc. (LNTH) scores 6.5/10 on AlphaStocks' five-model composite, #29 of 168 Health Care stocks. At $101, LNTH trades 10% below its model fair value of $112.
Health Care / Health Care Supplies
S&P MidCap 400$100.59
Middle of the pack. No strong signal either way.
Consider Buy
Score based on 5 of 5 models — high confidence
Data as of Sep 19, 2026
Is Lantheus Holdings, Inc. a Good Investment in 2026?
Lantheus Holdings, Inc. (LNTH) scores 6.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Lantheus Holdings, Inc. as Attractive (5/9). However, the Graham model rates it Caution — Significantly above fair value. Lantheus Holdings, Inc. currently trades 10% below its estimated fair value of $112. Lantheus Holdings, Inc. ranks #29 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading slightly below estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Attractive
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Neutral
PEG 1.3 · Fast Grower
Greenblatt
Neutral
Earnings yield 4.2% · ROC 43%
Frequently Asked Questions
Is Lantheus Holdings, Inc. (LNTH) a good investment?
What is Lantheus Holdings, Inc.'s Piotroski F-Score?
Is LNTH overvalued or undervalued?
How does LNTH compare to other Health Care stocks?
What do investment models say about LNTH?
Similar Stocks
Compare LNTH with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer